EFFICACY AND SAFETY OF ROMOSOZUMAB AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND MILD-TO-MODERATE CHRONIC KIDNEY DISEASE

被引：9

作者：

Miller, P. ^{[1
]}

Adachi, J. ^{[2
,3
]}

Albergaria, B. H. ^{[4
]}

Cheung, A. M. ^{[5
]}

Chines, A. ^{[6
]}

Gielen, E. ^{[7
,8
]}

Langdahl, B. ^{[9
]}

Miyauchi, A. ^{[10
]}

Oates, M. ^{[6
]}

Reid, I. ^{[11
]}

Santiago, N. Ruiz ^{[6
]}

Vanderkelen, M. ^{[12
]}

Yang, W. ^{[6
]}

Yu, Z. ^{[6
]}

机构：

[1] Colorado Ctr Bone Res, Golden, CO USA

[2] McMaster Univ, Hamilton, ON, Canada

[3] St Josephs Healthcare Hamilton, Hamilton, ON, Canada

[4] Univ Fed Espirito Santo, Vitoria, ES, Brazil

[5] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada

[6] Amgen Inc, Thousand Oaks, CA 91320 USA

[7] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, UZ Leuven, Gerontol & Geriatr, Leuven, Belgium

[8] Ctr Metab Bone Dis, Leuven, Belgium

[9] Aarhus Univ Hosp, Aarhus, Denmark

[10] Miyauchi Med Ctr, Osaka, Japan

[11] Univ Auckland, Auckland, New Zealand

[12] UCB Pharma, Brussels, Belgium

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷

关键词：

D O I：

10.1136/annrheumdis-2020-eular.4539

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OP0297

引用

页码：185 / 185

页数：1

共 50 条

[21] Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
Lim, Sian Yik
[J]. WOMENS HEALTH, 2022, 18
[22] Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
Lim, Sian Yik
[J]. WOMENS HEALTH, 2022, 18
[23] EVALUATION OF THE SAFETY AND EFFICACY OF ENALAPRIL IN MILD-TO-MODERATE HYPERTENSION
KOHAN, R
GOREN, Y
FRAJEWICKI, V
RUDOY, Y
LEIBA, M
BENARI, J
[J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1988, 43 (03): : 355 - 360
[24] A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis
Singh, S.
Dutta, S.
Khasbage, S.
Kumar, T.
Sachin, J.
Sharma, J.
Varthya, S. B.
[J]. OSTEOPOROSIS INTERNATIONAL, 2022, 33 (01) : 1 - 12
[25] A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis
S. Singh
S. Dutta
S. Khasbage
T. Kumar
J. Sachin
J. Sharma
S B Varthya
[J]. Osteoporosis International, 2022, 33 : 1 - 12
[26] Safety and efficacy of donepezil in African Americans with mild-to-moderate Alzheimer's disease
Griffith, Patrick
Lichtenberg, Peter
Goldman, Robert
Payne-Parrish, Jennifer
[J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (10) : 1590 - 1597
[27] Moxonidine and its safety in patients with mild-to-moderate hypertension and chronic pulmonary disease
Feuring, M
Cassel, W
Gasser, S
Thun, B
Grote, L
Wehling, M
Peter, JH
von Wichert, P
[J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R165 - R165
[28] Sarcopenia is associated with mild-to-moderate chronic kidney disease in Chinese community-dwelling older men but not in women
Chen, Xiaoyu
Zhu, Xiaoyan
Han, Peipei
Zhang, Yuanyuan
He, Mian
Zhang, Yuhui
Liu, Jinghuan
Tang, Jiawei
Zhang, Yisong
Zheng, Yaqing
Zhang, Ziwei
Li, Ming
Guo, Qi
[J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (11)
[29] Chronic Kidney Disease Progression and Outcome According to Serum Phosphorus in Mild-to-Moderate Kidney Dysfunction
Bellasi, Antonio
Mandreoli, Marcora
Baldrati, Leopoldo
Corradini, Matteo
Di Nicolo, Pierpaolo
Malmusi, Giulio
Santoro, Antonio
[J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (04): : 883 - 891
[30] Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment
P. D. Miller
E. N. Schwartz
P. Chen
D. A. Misurski
J. H. Krege
[J]. Osteoporosis International, 2007, 18 : 59 - 68

← 1 2 3 4 5 →